Jane Chung

Jane Chung is a declared insider of Sutro Biopharma, Inc., with filings sourced from SEC (Form 4). The record holds 31 filings, for trades running from 9 August 2022 to 4 March 2026.

The open-market record is one-sided, with 1 purchase worth €8,596 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants and 16 option exercises.

On 6 March 2026 came the latest disclosure, a share grant for €5,175 in Sutro Biopharma, Inc. The most recent open-market purchase was published on 16 October 2025, 372 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.